Biofrontera Statistics
NASDAQ: BFRIHealth CareBiotechnology: Pharmaceutical PreparationsUSD
0.902-0.0334 (-3.57%)
Market open · Delayed 15 min · as of Oct 8, 10:30 AM ET
Biofrontera by the numbers
Biofrontera has a market capitalization of $13.4 million based on 14.85M shares outstanding. With trailing EPS of $-0.43, Biofrontera is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 30.4% below its 50-day average and 12.0% below its 200-day average.
Average daily trading volume is 550.61K shares, or about $496,650 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
BFRI valuation vs. peer median
| Metric | BFRI | Peer median | Difference |
|---|---|---|---|
| Market cap | $13.40M | $13.91M | -4% |
| Avg. volume | 550.61K | 533.85K | +3% |
Peer median across 8 companies: CLRB, TVRD, KPTI, LSTA, BFRG, HIND, CTXR, TPST.
Valuation
- Market cap
- $13.40M
- Forward P/E
- 2.10
- EPS (TTM)
- $-0.43
- Shares outstanding
- 14.85M
Price and trading
- Previous close
- 0.9354
- Open
- 0.9355
- Day range
- 0.90 – 0.9503
- 52-week range
- 0.555 – 1.66
- 52-week change
- -10.06%
- Beta
- —
- Volume
- 123.14K
- Average volume
- 550.61K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 13, 2026
Additional statistics
- Market Cap
- 13.40M
- Forward Pe
- 2.10
- Eps
- -0.43
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 1.66
- Week52 Low
- 0.56
- Avg Volume
- 550.61K
- Shares Outstanding
- 14.85M
- Ma50
- 1.30
- Ma200
- 1.03
- Earnings Date
- Aug 13, 2026
- Pct From52w High
- -45.66%
- Pct From52w Low
- 62.52%